| Study Period | 2021 - 2032 |
| Market Size in 2025 | USD 7.1 Billion |
| Market Size in 2026 | USD 7.6 Billion |
| Market Size by 2032 | USD 11.6 Billion |
| Projected CAGR | 7.3% |
| Largest Region | North America |
| Fastest-Growing Region | Asia-Pacific |
| Market Structure | Semi-Consolidated |
Explore the market potential with our data-driven report
The brain monitoring market size was USD 7.1 billion for 2025, and it will grow by 7.3% during 2026–2032, to reach USD 11.6 billion by 2032.
The increasing number of people with neurological disorders worldwide is adding to the sale of brain monitoring devices. According to the U.S. National Library of Medicine, there are more than 600 neurological diseases. In addition, the upgradation in technology is expected to boost the market growth during the forecast period.
The growing geriatric population is further contributing to the demand for brain monitoring systems, as aging is closely associated with a higher prevalence of neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. The increasing utilization of brain monitoring devices in intensive care units (ICUs) for continuous monitoring of patients with traumatic brain injuries, stroke, and coma is significantly supporting market growth. Additionally, the rising number of neurosurgical procedures is driving the adoption of intraoperative brain monitoring technologies to enhance surgical precision and improve patient outcomes.
A defining transformation reshaping the brain monitoring market is the convergence of artificial intelligence, miniaturised sensor engineering, and wireless connectivity into next-generation monitoring platforms, enhancing both clinical utility and deployment flexibility while enabling broader, continuous use beyond traditional settings. Traditionally, electroencephalography (EEG) systems relied on conductive gels, scalp electrodes, and specialist-operated equipment confined to clinical laboratories, limiting their use to acute and episodic monitoring. Advancements in signal processing and sensor technologies now enable accurate neural data acquisition through dry electrode systems, in-ear EEG devices, and wearable headsets, making continuous monitoring feasible across hospital, home-care, and ambulatory settings. This expanded capability is extending the applicability of brain monitoring solutions beyond tertiary care hospitals into neurology clinics, ambulatory surgery centers, and remote care environments.
Increasing investments and real-world deployment of AI-enabled neurodiagnostic systems, supported by initiatives such as the BRAIN Initiative, are accelerating innovation in brain–computer interfaces, high-resolution neural recording, and AI-based diagnostics. Cleveland Clinic and other leading healthcare institutions are actively testing AI-powered EEG interpretation systems capable of analysing large volumes of brainwave data within seconds, enabling faster detection of neurological abnormalities and improving clinical decision-making efficiency. The integration of cloud-based platforms with advanced analytics is enabling remote neurological data interpretation while reducing reliance on on-site specialists, thereby addressing workforce limitations and expanding access to care. Higher demand for consumables such as electrodes, sensors, and caps across diverse care settings is a direct commercial consequence of this shift.
The escalating prevalence of neurological disorders represents the most fundamental driver of sustained demand across the brain monitoring market. As populations age globally, conditions including traumatic brain injury, dementia, epilepsy, Parkinson's disease, and stroke are becoming increasingly prevalent, each requiring continuous, diagnostic, or intraoperative monitoring to support clinical decision-making and long-term patient management. The World Health Organization has reported that neurological conditions affect over 3 billion people globally, representing a significant share of the population, with the overall burden increasing by around 18% since 1990. This rising disease burden directly translates into increased patient volumes across neurology departments, intensive care units, and ambulatory settings, driving higher institutional procurement of EEG devices, intracranial pressure monitors, cerebral oximeters, and associated accessories. This pattern is pronounced in high-income countries with aging populations and in rapidly urbanizing middle-income economies experiencing rising cardiovascular risk factors such as hypertension and diabetes, which contribute to a higher incidence of stroke and vascular dementia.
The World Health Organization identifies neurological disorders as the leading cause of disability globally while also highlighting that fewer than one in three countries have a national policy addressing these conditions, underscoring a persistent gap between disease burden and care infrastructure. In response, governments are strengthening neurological care delivery systems. For instance, the National Health Service is expanding access to early diagnosis and neurodiagnostic services under its long-term healthcare strategies, thereby accelerating the adoption of brain monitoring technologies across hospitals and specialized neurology centers. As this gap narrows over the forecast period, it is expected to generate sustained demand for advanced brain monitoring technologies across both developed and emerging markets.
Despite robust demand fundamentals, the global brain monitoring market faces a structural restraint in the combination of high device acquisition costs and a shortage of trained neurologists and EEG technicians. Both are required to operate advanced monitoring systems and interpret their outputs. Capital-intensive platforms such as functional MRI, magnetoencephalography (MEG) systems, and high-density EEG arrays require substantial procurement investments. These costs remain out of reach for many public healthcare systems in low- and middle-income countries, where the neurological disease burden is high.
Workforce limitations compound this challenge. According to the World Health Organization, low-income countries have more than 80 times fewer neurologists per capita compared to high-income nations, creating a structural mismatch between technology availability and the clinical expertise required to derive diagnostic value from these systems. Even in higher-income markets, shortages of EEG-trained technologists create utilization gaps, where hospitals may procure monitoring equipment but are unable to operate it at full capacity. This limits return on investment and slows upgrade cycles. Advancements in automated interpretation tools and simplified device interfaces are mitigating this constraint, but addressing the workforce gap will require long-term investments in healthcare training and education. This restraint will continue to moderate overall market growth through the forecast period
A structural opportunity for brain monitoring market participants lies in the intersection of global demographic ageing and the limitations of existing neurology care infrastructure. Traditional hospital-centric pathways are under strain as patient volumes rise. Dementia, one of the fastest-growing neurological conditions, currently affects approximately 55 million people worldwide, and according to the World Health Organization, the number of people living with dementia is projected to reach 139 million by 2050. Epilepsy affects approximately 50 million people globally, with a large proportion of patients requiring continuous or long-term brain activity monitoring for effective disease management. Stroke remains a leading neurological condition and a major cause of long-term disability, increasing the need for ongoing monitoring and follow-up care. This expanding neurological disease burden, combined with ageing populations, is making hospital-centric monitoring models increasingly unsustainable.
This dynamic is creating an opportunity for wearable, home-use, and remote brain monitoring solutions, including portable EEG systems and telehealth-integrated monitoring platforms that enable continuous tracking of neurological parameters outside hospital settings. The World Health Organization estimates that the global population aged 60 years and above will reach 2.1 billion by 2050, significantly expanding the population requiring long-term neurological monitoring. These solutions support earlier intervention and help reduce costly emergency and inpatient care events. As reimbursement frameworks in regions such as the U.S., Europe, and Japan increasingly support remote patient monitoring, adoption is expected to accelerate, positioning home-based brain monitoring as a key growth avenue across the market.
The device category holds the larger market share, of 70%, in 2025, driven by high-cost systems such as MRI, CT (neuroimaging modalities), EEG, and intracranial pressure monitors, which serve as the primary revenue contributors. These devices involve substantial upfront investments, long replacement cycles, and continuous technological upgrades. Expanding hospital infrastructure and increasing neurodiagnostic capacity are further driving device procurement, resulting in a higher revenue share compared to lower-cost consumables and software. According to the Centers for Disease Control and Prevention, traumatic brain injuries resulted in approximately 214,110 TBI-related hospitalizations in 2020 and 68,663 TBI-related deaths in 2023, sustaining strong demand for device-based monitoring technologies such as EEG systems, intracranial pressure monitors, and cerebral oximeters in critical care settings.
The accessories category will have the higher CAGR, of approximately 7.5%, driven by the recurring and high-volume demand for consumables such as electrodes, sensors, and caps used in brain monitoring procedures. These components require frequent replacement across continuous and long-term monitoring applications. The expansion of home-based care, ambulatory monitoring, and increasing procedure volumes further supports sustained consumption, resulting in faster growth compared to capital-intensive devices. Among these, electrodes remain the largest sub-segment due to their essential role in EEG monitoring, while sensors are the fastest-growing due to increasing adoption of wearable and non-invasive neurodiagnostic systems. Meanwhile, disposable accessories are also expanding rapidly due to infection control standards in hospital environments.
The products analyzed in this report are:
The traumatic brain injury category holds the largest market share in 2025, driven by the high incidence of head injuries from accidents, falls, and sports-related trauma. TBI requires continuous brain activity monitoring, increasing demand for advanced neurodiagnostic systems in emergency and critical care settings. According to the World Health Organization, traumatic brain injuries contribute to approximately 69 million cases globally each year, significantly reinforcing the need for real-time brain monitoring solutions across hospitals and trauma care units.
The dementia category will have the highest CAGR, of approximately 7.8%, driven by the accelerating global ageing population and the increasing need for early and continuous neurological monitoring in both at-risk and diagnosed individuals. Ambulatory EEG systems and portable cerebral oximeters are being integrated into dementia care pathways. These technologies support early detection of neurodegenerative changes, track disease progression, and evaluate treatment outcomes. The global prevalence of Alzheimer’s disease and other dementias has increased significantly, rising by approximately 160.8% between 1990 and 2021, further reinforcing demand for advanced monitoring solutions.
The applications analyzed in this report are:
The hospitals category holds the largest market share, of 45%, in 2025, due to the high concentration of advanced neurodiagnostic infrastructure, availability of skilled neurologists, and the need for continuous monitoring in critical care and surgical settings. Hospitals serve as the primary centers for diagnosis, treatment, and management of complex neurological conditions, driven by the fact that neurological disorders affect more than 1 in 3 people globally (WHO) and require specialized institutional care in hospital environments for acute and chronic management.
The ambulatory surgery centers & clinics category will have the highest CAGR, driven by increasing decentralization of healthcare services and rising demand for outpatient neurological diagnostics. Government healthcare reforms promoting outpatient care delivery are significantly supporting growth in this segment, such as CMS reimbursement support for outpatient neurological care, which is accelerating the shift from hospital-based diagnostics to cost-efficient ambulatory settings
The end users analyzed in this report are:
Drive strategic growth with comprehensive market analysis
North America holds the largest market share, of 40%, in 2025, attributed to the increase in the incidence of neurological diseases, adoption of advanced neurological diagnosis & monitoring technologies, and rise in the geriatric population. The rising awareness of the early detection of neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s, is driving the industry growth in this region.
Moreover, the region also benefits from strong healthcare infrastructure and high neurodiagnostic adoption rates, particularly in the United States, where neurological disorders are among the leading causes of disability. According to the Alzheimer’s Association, more than 6.9 million Americans aged 65 and older are living with Alzheimer’s disease, significantly increasing demand for advanced brain monitoring and neuroimaging systems across hospitals and neurology centers.
The United States is the largest country market globally for brain monitoring, supported by a well-established healthcare infrastructure and a high concentration of neurocritical care units. Continuous EEG monitoring, intracranial pressure management, and cerebral oximetry are routinely deployed in these settings for patients with severe neurological conditions. These specialized care environments create a strong and sustained installed base for advanced brain monitoring technologies, further supported by reimbursement frameworks under Medicare and Medicaid that provide financial predictability and encourage continued capital investment.
The integration of advanced and AI-assisted EEG interpretation systems is enhancing clinical efficiency and expanding the use of brain monitoring across ambulatory and real-world settings. Regulatory support from the U.S. Food and Drug Administration continues to facilitate the approval of innovative monitoring solutions, including portable and in-ear EEG devices. The high burden of neurological conditions further reinforces demand, with the Centers for Disease Control and Prevention reporting over 69,000 traumatic brain injury-related deaths in 2021, equivalent to approximately 190 deaths per day, underscoring the critical need for continuous and emergency brain monitoring systems.
Asia-Pacific will have the highest CAGR, of approximately 8.2%, driven by both demand-side and supply-side factors across its major economies. China, India, Japan, and South Korea collectively represent the primary growth engines, each advancing along distinct but complementary healthcare development trajectories. The region’s large and rapidly ageing population, combined with the rising incidence of neurological conditions such as stroke, dementia, and epilepsy, is significantly increasing demand for brain monitoring technologies.
Expanding healthcare infrastructure and demographic shifts are reinforcing country-level growth. India is witnessing a rising demand for neurological care, supported by the expansion of primary healthcare services under the National Health Mission, with over 1.7 lakh Ayushman Arogya Mandirs improving access to diagnostic and primary care services. South Korea and Australia are strengthening healthcare infrastructure and increasing adoption of advanced diagnostic technologies, supporting overall regional market growth.
China holds the largest share in the Asia-Pacific brain monitoring market, driven by the scale of its healthcare system, expanding hospital infrastructure, and strong government support for advanced medical technologies. The country has a rapidly growing network of tertiary hospitals and specialized neurology centers, enabling widespread adoption of brain monitoring devices across clinical settings.
In addition, rising disease burden is a key demand driver, with the World Health Organization identifying stroke as a leading cause of death in China, necessitating continuous neurological monitoring and early diagnosis. Furthermore, according to the National Bureau of Statistics of China, the country’s research and development expenditure exceeded 3.6 trillion yuan in recent years, supporting innovation and accelerating the adoption of advanced brain monitoring technologies.
These regions and countries are analysed:
The market is semi-consolidated because a small group of multinational companies, including Medtronic, GE HealthCare, Koninklijke Philips N.V., and Siemens Healthineers, hold a significant share, particularly in high-value imaging and integrated monitoring systems. These players benefit from strong global distribution, established hospital relationships, and continuous innovation. However, the market also includes numerous mid-sized and specialized firms focusing on EEG, sleep monitoring, and intracranial pressure devices. This segment-level diversity prevents dominance by a few firms across all categories and maintains balanced competitive intensity across the market.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages